In This Section

Division for Cancer Pharmacology – Young Investigators Symposium

Monday April 23, 2018

3:30 pm - 6:00 pm

Room 15B
Sponsored by the Division for Cancer Pharmacology (DCP)

Chair :

Christine Canman
University of Michigan Medical School

Jack Yalowich
Ohio State University

This session showcases abstract-based oral presentations by graduate student and postdoctoral ASPET members focused on cancer pharmacology.

GPR68, A Proton Sensing GPCR, Mediates Interaction of Pancreatic Cancer Associated Fibroblasts and Cancer Cells
Shu Wiley - University of California, San Diego

Deciphering the Role of SLX4IP in Telomere Maintenance Mechanisms
Tawna Whited - Case Western Reserve University

S100A8 and S100A9 Proteins in Tyrosine Kinase Inhibitor Resistance in FLT3-ITD-Positive Acute Myeloid Leukemia
Megan Zavorka Thomas - The Ohio State University

Structural Characterization of KRAS with a Novel Interactor, Argonaute 2
Jessica Waninger - University of Michigan Ann Arbor

Bioengineered let-7c is Effective at Reducing Orthotopic Hepatocellular Carcinoma Tumor Burden and is Well Tolerated in Mouse Models
Joseph Jilek - University of California, Davis

Genetic Ablation of the ABC Transporter Abcc4 Impairs Lymphoid Leukemogenesis
Rebecca Crawford - St Jude Children's Research Hospital

Tumor Suppressor Alpha-arrestin ARRDC3 Controls GPCR Signaling and Breast Cancer Chemoresistance
Wen An Pan - University of California, San Diego

Thank you to our Annual Meeting partners:

University of Florida
Wake Forest University
Washington State University College of Pharmacy and Pharmaceutical Sciences
University of Wisconsin Molecular and Cellular Pharmacology Training Program
UT Health San Antonio
University of Minnesota

Emory University Pharmacology

PR & P
University of Michigan Medical School Pharmacology